Abstract
The ability to reprogram adult somatic cells into human induced pluripotent stem cells (hiPSCs), and to differentiate them into nearly any cell type in vitro, has revolutionized cell biology. hiPSCs have become an essential model for advancing regenerative medicine and developing personalized therapies. However, hiPSC cultures often show significant variability in vitro, even among lines derived from the same donor. To achieve statistically robust and reproducible results, researchers must work with large cohorts and scalable, standardized processes. Automation is key.
In this webinar, Dr. Thorsten Schlaeger, from Boston Children's Hospital will present how his team has utilized the Formulatrix Cellmatic™ to automate hiPSC expansion workflows. Dr. Schlaeger will demonstrate how the Cellmatic™ system supports critical functions such as gentle media exchange, clump (and single cell) passaging, real-time confluency and morphology monitoring, and standardized plating protocols. With its concurrent and dynamic scheduling capability, the Cellmatic allows multiple protocols to run in parallel, significantly increasing throughput and consistency.
Please join us for this special webinar to learn more about automated iPSC workflows and how the Stem Cell Core Facility at Boston Children's Hospital is utilizing it to further their scientific endeavors.
When
July 24th 2025
Session 1
10:00 AM - 10:30 AM CEST
(09:00 AM - 09:30 AM BST)
Session 2
01:00 PM - 01:30 PM ET
(10:00 AM - 10:30 AM PT)
About the Speaker:
Dr. Thorsten Schlaeger holds a PhD in Human Biology from Philipps University, Germany, and received the Otto Hahn Medal for his research on endothelial gene regulation. He has conducted postdoctoral work at Boston Children’s Hospital, studying stem cell leukemia genes, and later led gene targeting projects in industry. Since 2005, he has headed the Human Embryonic Stem Cell Core Facility at Boston Children’s Hospital.